Global Equine Influenza Vaccine Market Research Report 2020

Global Equine Influenza Vaccine Market Research Report 2020

Feb 2020 QYResearch Pharmaceutical97 Pages Price :
$ 2900
This report focuses on Equine Influenza Vaccine volume and value at global level, regional level and company level. From a global perspective, this report represents overall Equine Influenza Vaccine market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
Zoetis
Merck Animal Health
Boehringer Ingelheim Vetmedica
...

Segment by Regions
North America
Europe
China
Japan

Segment by Type
Liquid
Powder

Segment by Application
Home
Pet Clinic
Other


Table of Contents

1 Equine Influenza Vaccine Market Overview
1.1 Product Overview and Scope of Equine Influenza Vaccine
1.2 Equine Influenza Vaccine Segment by Type
1.2.1 Global Equine Influenza Vaccine Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Liquid
1.2.3 Powder
1.3 Equine Influenza Vaccine Segment by Application
1.3.1 Equine Influenza Vaccine Sales Comparison by Application: 2020 VS 2026
1.3.2 Home
1.3.3 Pet Clinic
1.3.4 Other
1.4 Global Equine Influenza Vaccine Market Size Estimates and Forecasts
1.4.1 Global Equine Influenza Vaccine Revenue 2015-2026
1.4.2 Global Equine Influenza Vaccine Sales 2015-2026
1.4.3 Equine Influenza Vaccine Market Size by Region: 2020 Versus 2026

2 Global Equine Influenza Vaccine Market Competition by Manufacturers
2.1 Global Equine Influenza Vaccine Sales Market Share by Manufacturers (2015-2020)
2.2 Global Equine Influenza Vaccine Revenue Share by Manufacturers (2015-2020)
2.3 Global Equine Influenza Vaccine Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Equine Influenza Vaccine Manufacturing Sites, Area Served, Product Type
2.5 Equine Influenza Vaccine Market Competitive Situation and Trends
2.5.1 Equine Influenza Vaccine Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Equine Influenza Vaccine Players (Opinion Leaders)

3 Equine Influenza Vaccine Retrospective Market Scenario by Region
3.1 Global Equine Influenza Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Equine Influenza Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Equine Influenza Vaccine Market Facts & Figures by Country
3.3.1 North America Equine Influenza Vaccine Sales by Country
3.3.2 North America Equine Influenza Vaccine Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Equine Influenza Vaccine Market Facts & Figures by Country
3.4.1 Europe Equine Influenza Vaccine Sales by Country
3.4.2 Europe Equine Influenza Vaccine Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Equine Influenza Vaccine Market Facts & Figures by Region
3.5.1 Asia Pacific Equine Influenza Vaccine Sales by Region
3.5.2 Asia Pacific Equine Influenza Vaccine Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Equine Influenza Vaccine Market Facts & Figures by Country
3.6.1 Latin America Equine Influenza Vaccine Sales by Country
3.6.2 Latin America Equine Influenza Vaccine Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Equine Influenza Vaccine Market Facts & Figures by Country
3.7.1 Middle East and Africa Equine Influenza Vaccine Sales by Country
3.7.2 Middle East and Africa Equine Influenza Vaccine Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Equine Influenza Vaccine Historic Market Analysis by Type
4.1 Global Equine Influenza Vaccine Sales Market Share by Type (2015-2020)
4.2 Global Equine Influenza Vaccine Revenue Market Share by Type (2015-2020)
4.3 Global Equine Influenza Vaccine Price Market Share by Type (2015-2020)
4.4 Global Equine Influenza Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Global Equine Influenza Vaccine Historic Market Analysis by Application
5.1 Global Equine Influenza Vaccine Sales Market Share by Application (2015-2020)
5.2 Global Equine Influenza Vaccine Revenue Market Share by Application (2015-2020)
5.3 Global Equine Influenza Vaccine Price by Application (2015-2020)

6 Company Profiles and Key Figures in Equine Influenza Vaccine Business
6.1 Zoetis
6.1.1 Corporation Information
6.1.2 Zoetis Description, Business Overview and Total Revenue
6.1.3 Zoetis Equine Influenza Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Zoetis Products Offered
6.1.5 Zoetis Recent Development
6.2 Merck Animal Health
6.2.1 Merck Animal Health Equine Influenza Vaccine Production Sites and Area Served
6.2.2 Merck Animal Health Description, Business Overview and Total Revenue
6.2.3 Merck Animal Health Equine Influenza Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Merck Animal Health Products Offered
6.2.5 Merck Animal Health Recent Development
6.3 Boehringer Ingelheim Vetmedica
6.3.1 Boehringer Ingelheim Vetmedica Equine Influenza Vaccine Production Sites and Area Served
6.3.2 Boehringer Ingelheim Vetmedica Description, Business Overview and Total Revenue
6.3.3 Boehringer Ingelheim Vetmedica Equine Influenza Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Boehringer Ingelheim Vetmedica Products Offered
6.3.5 Boehringer Ingelheim Vetmedica Recent Development

7 Equine Influenza Vaccine Manufacturing Cost Analysis
7.1 Equine Influenza Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Equine Influenza Vaccine
7.4 Equine Influenza Vaccine Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Equine Influenza Vaccine Distributors List
8.3 Equine Influenza Vaccine Customers

9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis

10 Global Market Forecast
10.1 Global Equine Influenza Vaccine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Equine Influenza Vaccine by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Equine Influenza Vaccine by Type (2021-2026)
10.2 Equine Influenza Vaccine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Equine Influenza Vaccine by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Equine Influenza Vaccine by Application (2021-2026)
10.3 Equine Influenza Vaccine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Equine Influenza Vaccine by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Equine Influenza Vaccine by Region (2021-2026)
10.4 North America Equine Influenza Vaccine Estimates and Projections (2021-2026)
10.5 Europe Equine Influenza Vaccine Estimates and Projections (2021-2026)
10.6 Asia Pacific Equine Influenza Vaccine Estimates and Projections (2021-2026)
10.7 Latin America Equine Influenza Vaccine Estimates and Projections (2021-2026)
10.8 Middle East and Africa Equine Influenza Vaccine Estimates and Projections (2021-2026)
11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Table

List of Tables
Table 1. Global Equine Influenza Vaccine Sales (K Doses) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Equine Influenza Vaccine Sales (K Doses) Comparison by Application: 2020 VS 2026
Table 3. Global Equine Influenza Vaccine Market Size by Type (K Doses) (US$ Million) (2020 VS 2026)
Table 4. Global Key Equine Influenza Vaccine Manufacturers Covered in This Study
Table 5. Global Equine Influenza Vaccine Sales (K Doses) by Manufacturers (2015-2020)
Table 6. Global Equine Influenza Vaccine Sales Share by Manufacturers (2015-2020)
Table 7. Global Equine Influenza Vaccine Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Equine Influenza Vaccine Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Equine Influenza Vaccine Average Price (USD/Dose) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Equine Influenza Vaccine Sales Sites and Area Served
Table 11. Manufacturers Equine Influenza Vaccine Product Types
Table 12. Global Equine Influenza Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Equine Influenza Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Equine Influenza Vaccine as of 2019)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Equine Influenza Vaccine Players
Table 16. Global Equine Influenza Vaccine Sales (K Doses) by Region (2015-2020)
Table 17. Global Equine Influenza Vaccine Sales Market Share by Region (2015-2020)
Table 18. Global Equine Influenza Vaccine Revenue (Million US$) by Region (2015-2020)
Table 19. Global Equine Influenza Vaccine Revenue Market Share by Region (2015-2020)
Table 20. North America Equine Influenza Vaccine Sales by Country (2015-2020) (K Doses)
Table 21. North America Equine Influenza Vaccine Sales Market Share by Country (2015-2020)
Table 22. North America Equine Influenza Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Equine Influenza Vaccine Revenue Market Share by Country (2015-2020)
Table 24. Europe Equine Influenza Vaccine Sales by Country (2015-2020) (K Doses)
Table 25. Europe Equine Influenza Vaccine Sales Market Share by Country (2015-2020)
Table 26. Europe Equine Influenza Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Equine Influenza Vaccine Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Equine Influenza Vaccine Sales by Region (2015-2020) (K Doses)
Table 29. Asia Pacific Equine Influenza Vaccine Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Equine Influenza Vaccine Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Equine Influenza Vaccine Revenue Market Share by Region (2015-2020)
Table 32. Latin America Equine Influenza Vaccine Sales by Country (2015-2020) (K Doses)
Table 33. Latin America Equine Influenza Vaccine Sales Market Share by Country (2015-2020)
Table 34. Latin America Equine Influenza Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Equine Influenza Vaccine Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Equine Influenza Vaccine Sales by Country (2015-2020) (K Doses)
Table 37. Middle East and Africa Equine Influenza Vaccine Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Equine Influenza Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Equine Influenza Vaccine Revenue Market Share by Country (2015-2020)
Table 40. Global Equine Influenza Vaccine Sales (K Doses) by Type (2015-2020)
Table 41. Global Equine Influenza Vaccine Sales Share by Type (2015-2020)
Table 42. Global Equine Influenza Vaccine Revenue (Million US$) by Type (2015-2020)
Table 43. Global Equine Influenza Vaccine Revenue Share by Type (2015-2020)
Table 44. Global Equine Influenza Vaccine Price (USD/Dose) by Type (2015-2020)
Table 45. Global Equine Influenza Vaccine Sales (K Doses) by Application (2015-2020)
Table 46. Global Equine Influenza Vaccine Sales Market Share by Application (2015-2020)
Table 47. Global Equine Influenza Vaccine Sales Growth Rate by Application (2015-2020)
Table 48. Zoetis Equine Influenza Vaccine Corporation Information
Table 49. Zoetis Description and Business Overview
Table 50. Zoetis Equine Influenza Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 51. Zoetis Main Product
Table 52. Zoetis Recent Development
Table 53. Merck Animal Health Equine Influenza Vaccine Corporation Information
Table 54. Merck Animal Health Corporation Information
Table 55. Merck Animal Health Equine Influenza Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 56. Merck Animal Health Main Product
Table 57. Merck Animal Health Recent Development
Table 58. Boehringer Ingelheim Vetmedica Equine Influenza Vaccine Corporation Information
Table 59. Boehringer Ingelheim Vetmedica Corporation Information
Table 60. Boehringer Ingelheim Vetmedica Equine Influenza Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 61. Boehringer Ingelheim Vetmedica Main Product
Table 62. Boehringer Ingelheim Vetmedica Recent Development
Table 63. Sales Base and Market Concentration Rate of Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Equine Influenza Vaccine Distributors List
Table 66. Equine Influenza Vaccine Customers List
Table 67. Market Key Trends
Table 68. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 69. Key Challenges
Table 70. Global Equine Influenza Vaccine Sales (K Doses) Forecast by Type (2021-2026)
Table 71. Global Equine Influenza Vaccine Sales Market Share Forecast by Type (2021-2026)
Table 72. Global Equine Influenza Vaccine Revenue (Million US$) Forecast by Type (2021-2026)
Table 73. Global Equine Influenza Vaccine Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 74. Global Equine Influenza Vaccine Sales (K Doses) Forecast by Application (2021-2026)
Table 75. Global Equine Influenza Vaccine Revenue (Million US$) Forecast by Application (2021-2026)
Table 76. Global Equine Influenza Vaccine Sales (K Doses) Forecast by Region (2021-2026)
Table 77. Global Equine Influenza Vaccine Sales Market Share Forecast by Region (2021-2026)
Table 78. Global Equine Influenza Vaccine Revenue Forecast by Region (2021-2026) (US$ Million)
Table 79. Global Equine Influenza Vaccine Revenue Market Share Forecast by Region (2021-2026)
Table 80. Research Programs/Design for This Report
Table 81. Key Data Information from Secondary Sources
Table 82. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Equine Influenza Vaccine
Figure 2. Global Equine Influenza Vaccine Sales Market Share by Type: 2020 VS 2026
Figure 3. Liquid Product Picture
Figure 4. Powder Product Picture
Figure 5. Global Equine Influenza Vaccine Consumption Market Share by Application: 2020 VS 2026
Figure 6. Home
Figure 7. Pet Clinic
Figure 8. Other
Figure 9. Global Equine Influenza Vaccine Market Size 2015-2026 (US$ Million)
Figure 10. Global Equine Influenza Vaccine Sales Capacity (K Doses) (2015-2026)
Figure 11. Global Equine Influenza Vaccine Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Equine Influenza Vaccine Sales Share by Manufacturers in 2020
Figure 13. Global Equine Influenza Vaccine Revenue Share by Manufacturers in 2019
Figure 14. The Global 5 and 10 Largest Players: Market Share by Equine Influenza Vaccine Revenue in 2019
Figure 15. Equine Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 16. Global Equine Influenza Vaccine Sales Market Share by Region (2015-2020)
Figure 17. Global Equine Influenza Vaccine Sales Market Share by Region in 2019
Figure 18. Global Equine Influenza Vaccine Revenue Market Share by Region (2015-2020)
Figure 19. Global Equine Influenza Vaccine Revenue Market Share by Region in 2019
Figure 20. North America Equine Influenza Vaccine Sales Market Share by Country in 2019
Figure 21. North America Equine Influenza Vaccine Revenue Market Share by Country in 2019
Figure 22. U.S. Equine Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 23. U.S. Equine Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 24. Canada Equine Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 25. Canada Equine Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 26. Europe Equine Influenza Vaccine Sales Market Share by Country in 2019
Figure 27. Europe Equine Influenza Vaccine Revenue Market Share by Country in 2019
Figure 28. Germany Equine Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 29. Germany Equine Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 30. France Equine Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 31. France Equine Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 32. U.K. Equine Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 33. U.K. Equine Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Italy Equine Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 35. Italy Equine Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Russia Equine Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 37. Russia Equine Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Asia Pacific Equine Influenza Vaccine Sales Market Share by Region in 2019
Figure 39. Asia Pacific Equine Influenza Vaccine Revenue Market Share by Region in 2019
Figure 40. China Equine Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 41. China Equine Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. Japan Equine Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 43. Japan Equine Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. South Korea Equine Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 45. South Korea Equine Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. India Equine Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 47. India Equine Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Australia Equine Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 49. Australia Equine Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Taiwan Equine Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 51. Taiwan Equine Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Indonesia Equine Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 53. Indonesia Equine Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Thailand Equine Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 55. Thailand Equine Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Malaysia Equine Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 57. Malaysia Equine Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Philippines Equine Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 59. Philippines Equine Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Vietnam Equine Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 61. Vietnam Equine Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Latin America Equine Influenza Vaccine Sales Market Share by Country in 2019
Figure 63. Latin America Equine Influenza Vaccine Revenue Market Share by Country in 2019
Figure 64. Mexico Equine Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 65. Mexico Equine Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Brazil Equine Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 67. Brazil Equine Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Argentina Equine Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 69. Argentina Equine Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Middle East and Africa Equine Influenza Vaccine Sales Market Share by Country in 2019
Figure 71. Middle East and Africa Equine Influenza Vaccine Revenue Market Share by Country in 2019
Figure 72. Turkey Equine Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 73. Turkey Equine Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Saudi Arabia Equine Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 75. Saudi Arabia Equine Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. U.A.E Equine Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 77. U.A.E Equine Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Sales Market Share of Equine Influenza Vaccine by Type (2015-2020)
Figure 79. Sales Market Share of Equine Influenza Vaccine by Type in 2019
Figure 80. Revenue Share of Equine Influenza Vaccine by Type (2015-2020)
Figure 81. Revenue Market Share of Equine Influenza Vaccine by Type in 2019
Figure 82. Global Equine Influenza Vaccine Sales Growth by Type (2015-2020) (K Doses)
Figure 83. Global Equine Influenza Vaccine Sales Market Share by Application (2015-2020)
Figure 84. Global Equine Influenza Vaccine Sales Market Share by Application in 2019
Figure 85. Global Revenue Share of Equine Influenza Vaccine by Application (2015-2020)
Figure 86. Global Revenue Share of Equine Influenza Vaccine by Application in 2020
Figure 87. Zoetis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 88. Merck Animal Health Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. Boehringer Ingelheim Vetmedica Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Price Trend of Key Raw Materials
Figure 91. Manufacturing Cost Structure of Equine Influenza Vaccine
Figure 92. Manufacturing Process Analysis of Equine Influenza Vaccine
Figure 93. Equine Influenza Vaccine Industrial Chain Analysis
Figure 94. Channels of Distribution
Figure 95. Distributors Profiles
Figure 96. Porter's Five Forces Analysis
Figure 97. North America Equine Influenza Vaccine Sales (K Doses) and Growth Rate Forecast (2021-2026)
Figure 98. North America Equine Influenza Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 99. Europe Equine Influenza Vaccine Sales (K Doses) and Growth Rate Forecast (2021-2026)
Figure 100. Europe Equine Influenza Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 101. Latin America Equine Influenza Vaccine Sales (K Doses) and Growth Rate Forecast (2021-2026)
Figure 102. Latin America Equine Influenza Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 103. Middle East and Africa Equine Influenza Vaccine Sales (K Doses) and Growth Rate Forecast (2021-2026)
Figure 104. Middle East and Africa Equine Influenza Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 105. Asia Pacific Equine Influenza Vaccine Sales (K Doses) and Growth Rate Forecast (2021-2026)
Figure 106. Asia Pacific Equine Influenza Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 107. Bottom-up and Top-down Approaches for This Report
Figure 108. Data Triangulation
Figure 109. Key Executives Interviewed

Ask for discount before buying this report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Country :
  • Your Requirement
  • Security Code *
* denotes fields which must be completed

Buy This Report


Select License Type :

$ 2900
$ 4350

Do you wish to check sample of this report?

Have Query?


Research Assistance

For Enquiries, Call :

+1-800-998-4852US Toll Free

Email : sales@marketresearchhub.com

Back To Top